Two of the FDA’s most senior vaccine leaders are exiting from their positions, raising fresh questions about the Biden administration and the way that it’s sidelined the FDA.
Marion Gruber, director of the FDA’s Office of Vaccines Research & Review and 32-year veteran of the agency, will leave at the end of October, and OVRR deputy director Phil Krause, who’s been at FDA for more than a decade, will leave in November. The news, first reported by BioCentury, is a massive blow to confidence in the agency’s ability to regulate vaccines.
- Tampax Sexualizing Periods Again
- Who Is Killing The Crypto Millionaires?
- At This Point They Aren’t Even Trying To Hide Who They Really Serve
- First Ever Americans Charged with Seditious Conspiracy
- Is Credit Suisse about to blow?
- Housing market crash is happening right now
- Michael Burry says the US economy will suffer a multiyear recession. He sees no way for authorities to end the downturn early and warns consumers will virtually exhaust their savings soon, tanking the economy.
- BIG LEAK– FDA COVID-19 Vaccine Working List Of Possible Adverse Event Outcomes
- Civil Unrest Explodes in China Over Lockdowns
- The Truth About The China Riots